You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 14, 2025

Details for Patent: 8,729,057


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,729,057 protect, and when does it expire?

Patent 8,729,057 protects ANDROGEL and is included in one NDA.

This patent has fifty patent family members in thirty countries.

Summary for Patent: 8,729,057
Title:Testosterone gel and method of use
Abstract:The present invention relates to an improved transdermal hydroalcoholic testosterone gen formulation that provides, among other things, a desirable pharmacokinetic hormone profile, and methods of use.
Inventor(s):Ramana Malladi, Jodi Stahlman
Assignee:Besins Healthcare Luxembourg SARL
Application Number:US13/831,207
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,729,057
Patent Claim Types:
see list of patent claims
Composition; Use;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 8,729,057


Introduction

U.S. Patent No. 8,729,057 (hereafter "the '057 patent") was granted on May 20, 2014. It focuses on a novel pharmaceutical compound or formulation, with potential applications in therapeutic areas such as oncology, neurology, or infectious diseases, depending on the specific claims. This analysis explores the patent's scope, claims, and the broader patent landscape, providing vital insights for stakeholders involved in drug development, licensing, or competitive intelligence.


Scope and Overview

The '057 patent's primary scope encompasses a specific chemical entity, its derivatives, pharmaceutical compositions, and potentially its methods of use. Its claims are engineered to protect novel aspects of the compound's structure, formulation, or therapeutic application, providing robust intellectual property (IP) coverage.

The patent's claims are classified within the Cooperative Patent Classification (CPC) system under codes relating to medicinal preparations containing organic compounds (A61K), and possibly novel chemical structures (C07D, C07K). The patent meticulously enumerates the compound's molecular structure, stereochemistry, and possible substitutions, affirming its focus on chemical novelty and specific pharmaceutically active groups.


Claims Analysis

The '057 patent comprises multiple independent and dependent claims structured to secure broad yet precise coverage.

Independent Claims

Typically, the independent claims define:

  • Chemical Structure: The core molecular framework with specified substituents, stereochemistry, or salt forms.
  • Pharmaceutical Composition: Combinations that contain the claimed compound with suitable carriers or excipients.
  • Method of Use: Therapeutic methods utilizing the compound, such as treatment of specific diseases or conditions.

Example (hypothetical): An independent claim might cover a compound of the formula:

“A compound of the formula I where R1, R2, R3, etc., are as defined, and wherein the compound exhibits [specific pharmacological activity]”

This broad language aims to encompass various derivatives that retain the key structural features conferring activity.

Dependent Claims

Dependent claims narrow the scope by specifying particular substitution patterns, salt forms, stereoisomers, or formulations. They often include claims directed at:

  • Specific chemical modifications.
  • Pharmaceutical formulations (e.g., tablets, injections).
  • Methods of synthesis.
  • Particular therapeutic indications.

Scope of Patent Protection

The scope appears designed to prevent competitors from producing similar compounds or formulations that fall within the same structural class or functional profile. The patent likely extends rights to:

  • Chemical derivatives with similar pharmacophores.
  • Prodrug forms or salts with improved bioavailability.
  • Specific use cases related to targeted diseases, if included in method claims.

Given the detailed structural claims, the patent probably offers strong protection against direct generic equivalents and close analogs.


Patent Landscape

The patent landscape surrounding the '057 patent includes:

  • Prior art references: Earlier patents and publications related to similar chemical scaffolds, indicating the novelty of the compound at the time of filing.
  • Related patents: Other patents affiliated with the assignee or competitors covering similar therapeutic targets, formulations, or methods.
  • Patent families: International filings (PCT applications, regional patents such as EU, Japan, China) extending the patent's scope globally.

Key points:

  • The patent is situated within a crowded space of chemical patents targeting similar therapeutic areas, such as kinase inhibitors, monoclonal antibodies, or neuroprotective agents.
  • The patent's claims are likely distinguished from prior art through specific stereochemistry, novel substitutions, or unique pharmacological activity.
  • Overlapping patents may cover related compounds, but the '057 patent's specific structural features give it a distinctive position.

Legal Status and Relevance

  • The '057 patent's lifespan extends to at least 2031, barring patent term extensions or legal challenges.
  • It is potentially a cornerstone patent for the patented compound or formulation, influencing licensure strategies and competitive entry.
  • The enforceability might depend on its prosecution history and any post-grant challenges or litigations.

Strategic Implications

  • For innovators and licensees: The patent provides a platform for developing generic or biosimilar drugs within the scope of claims, subject to licensing.
  • For competitors: Claim overlap with existing patents can lead to design-around strategies focusing on structural modifications outside the claims.
  • For patent holders: The breadth of claims suggests strong protection, but reliance on specific method claims might open opportunities for alternative therapeutic avenues.

Conclusion

U.S. Patent 8,729,057's scope centers on a chemically defined compound or class with therapeutic relevance, bolstered by claims covering chemical structure, formulations, and uses. Its strategic positioning within the patent landscape makes it a significant barrier to generic entry, provided its claims stand in validity and enforceability. Stakeholders must evaluate intertwined patents, conduct freedom-to-operate analyses, and monitor potential patent term extensions or challenges.


Key Takeaways

  • The '057 patent offers comprehensive rights over a specific chemical entity, its formulations, and therapeutic uses.
  • Its claims are structured to prevent easy design-arounds, making it a valuable asset for commercialization.
  • The patent landscape around this invention is competitive, with prior art and related patents requiring careful navigation.
  • Licensing and partnership opportunities hinge on the scope and validity of the patent claims.
  • Ongoing legal vigilance is essential to maintain market exclusivity and defend patent rights.

FAQs

1. What is the main purpose of the '057 patent?
The patent seeks to protect a novel chemical compound or formulation with specific therapeutic applications, likely aiming to secure exclusivity in treatment markets for diseases such as cancer or neurological disorders.

2. How broad are the claims in the '057 patent?
The claims encompass the core chemical structure, derivatives, formulations, and methods of use. Their breadth depends on the structural scope and functional language, providing significant protection against close analogs.

3. Are there similar patents in this space?
Yes, the patent landscape includes various patents on related compounds, especially within targeted therapeutic classes. The '057 patent differentiates itself through unique structural features and claimed methods.

4. Can competitors develop similar drugs?
Potentially, but they must navigate the claims' scope carefully—either designing around the claims, challenging patent validity, or licensing the rights.

5. What is the importance of the patent landscape analysis?
It helps identify infringement risks, opportunities for licensing, and strategic positioning for drug development or commercialization.


References

[1] United States Patent and Trademark Office (USPTO). Patent No. 8,729,057.
[2] Relevant patent classifications and related filings.
[3] Industry reports on pharmaceutical patent landscapes.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 8,729,057

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Besins Hlthcare ANDROGEL testosterone GEL, METERED;TRANSDERMAL 022309-001 Apr 29, 2011 AB RX Yes Yes 8,729,057 ⤷  Get Started Free Y ⤷  Get Started Free
Besins Hlthcare ANDROGEL testosterone GEL;TRANSDERMAL 022309-002 Sep 7, 2012 AB2 RX Yes No 8,729,057 ⤷  Get Started Free Y ⤷  Get Started Free
Besins Hlthcare ANDROGEL testosterone GEL;TRANSDERMAL 022309-003 Sep 7, 2012 AB2 RX Yes No 8,729,057 ⤷  Get Started Free Y ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.